首页 › 基金 › MACKAY SHIELDS LLC › BMRN
MACKAY SHIELDS LLC 对 BMRN 的持仓历史
BIOMARIN PHARMACEUTICAL INC COM · 医疗保健
MACKAY SHIELDS LLC 在 Q3 2026 的 13F 申报中披露持有 BMRN(BIOMARIN PHARMACEUTICAL INC COM)26,468,000 股,市值约 US$25.8M,约占其申报组合的 1.07%,在其申报持仓中市值排名第 40 位。 MACKAY SHIELDS LLC 最近 13 个申报季度中有 13 个季度披露了 BMRN 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-15 · 来源: SEC EDGAR Form 13F-HR
MACKAY SHIELDS LLC 对 BMRN 的持仓演变
MACKAY SHIELDS LLC 于 Q3 2023 首次披露 BMRN 持仓:9,891,000 股(约 US$9.6M)。 该持仓在 Q2 2024 达到峰值 72,514,000 股,市值约 US$69.5M。 在 13 次申报中,MACKAY SHIELDS LLC 1 次增持、8 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 26,468,000 股、市值约 US$25.8M。 持仓曾出现大幅变动:Q2 2024 增持约 720% (随后一个季度股价下跌 15%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 9.89M | $9.59M | 新进 |
| Q4 2023 | 9.07M | $8.94M | 减持 |
| Q1 2024 | 8.85M | $8.69M | 减持 |
| Q2 2024 | 72.51M | $69.48M | 增持 |
| Q3 2024 | 72.57M | $69.23M | 持有 |
| Q4 2024 | 61.74M | $57.51M | 减持 |
| Q1 2025 | 54.93M | $51.84M | 减持 |
| Q2 2025 | 44.30M | $41.84M | 减持 |
| Q3 2025 | 35.21M | $33.45M | 减持 |
| Q4 2025 | 34.66M | $33.27M | 减持 |
| Q1 2026 | 26.50M | $25.56M | 减持 |
| Q2 2026 | 26.43M | $25.74M | 持有 |
| Q3 2026 | 26.47M | $25.85M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BMRN 与 13F 数据
BMRN(BIOMARIN PHARMACEUTICAL INC COM)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 BMRN,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$812.0M), 维京环球投资 (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BMRN 的基金
- PRIMECAP MANAGEMENT CO/CA/ 14.19M 股 · $811.96M · Q2 2026
- 维京环球投资 7.62M 股 · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.62M 股 · $435.82M · Q2 2026
- Vestal Point Capital, LP 6.03M 股 · $344.75M · Q2 2026
- Deep Track Capital, LP 3.31M 股 · $189.25M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M 股 · $108.89M · Q2 2026
更多关于 MACKAY SHIELDS LLC
常见问题
How long has MACKAY SHIELDS LLC held BMRN?
MACKAY SHIELDS LLC has disclosed BMRN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is MACKAY SHIELDS LLC's current position in BMRN?
As of Q3 2026, MACKAY SHIELDS LLC holds 26.47M shares of BMRN (BIOMARIN PHARMACEUTICAL INC COM), valued at $25.85M, representing 1.07% of its reported portfolio and ranking #40.
Has MACKAY SHIELDS LLC been buying or selling BMRN?
In the latest 13F filing (Q3 2026), MACKAY SHIELDS LLC held unchanged its position in BMRN. The position peaked in Q2 2024 at 72.51M shares.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, 维京环球投资, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.